Hyderabad is the Life Sciences and Vaccine capital of India, with many inherent strengths in these sectors.


Hyderabad, the joint capital of Telangana and Andhra Pradesh, is the sixth largest urban agglomeration in India.

Hyderabad is one of the largest life sciences innovation and manufacturing hubs in India, producing a majority of global vaccine and national pharmaceutical products. Major global and Indian life sciences companies carry out cutting-edge research in their Hyderabad facilities. Genome Valley, Pharma City, Fab City and Public Sector Biotechnology establishments across the city have greatly strengthened the pharmaceutical industry in Hyderabad.

Hyderabad is also one of the first cities in India to embrace the IT/ITeS boom, which earned it the name of the ‘Silicon Valley of India’ in the 1990s and early 2000s. Hyderabad city is spread over five districts, namely Hyderabad, Ranga Reddy, Medak, Nalgonda and Mahboobnagar. The Hyderabad Metropolitan area comprises nearly 7,229 sq km.

Industrial activity in Hyderabad is broad based, with sectors like IT/ITES, biotechnology, apparel parks, pharmaceuticals, construction, etc., all having a presence in the city. IT/ITES, pharmaceutical and biotechnology industries are the dominant players and are expected to play an increasing role in the future.

With great support from the state government for industries, growing demand for industrial space is expected from industries including e-commerce, FMCG, electronics manufacturing, pharmaceuticals, life sciences and agro-based industries, in locations such as Medchal and Kompally in northern Hyderabad and Adibatla, Shamshabad and Fab City in southern Hyderabad.


Pharmaceutical Industry in Hyderabad

Hyderabad is the Life Sciences and Vaccine capital of India, with about 33% of all vaccines produced globally coming from Hyderabad, and 35-40% of India’s pharma production undertaken here. Some of the factors that give Hyderabad the edge in life sciences industry include:

  • Inherent strengths in basic and advanced sciences (chemistry, biology, IT, etc.), concentration of activities across verticals, and disease profile enabling seamless forward and backward linkages / integration for product development including clinical development and translational research.
  • Availability of ready to occupy facilities in various sizes with common facilities and large reserves of land.
  • High quality ecosystem with rich talent pool.
  • Home to India’s largest and only systematically developed biotech cluster – Genome Valley,  the first of its kind in the country. The Telangana government plans a first-of-its-kind Pharma city to further expand space for the pharmaceuticals industry.
  • Seed Capital of India – has the country’s first translational platform.
  • Home to India’s first Medical Devices Park with common facilities and incubation services.
  • Significant number of CROs / CMOs, vivariums and testing laboratories easing outsourcing.


MN Takshila Industries Pvt. Ltd.
Suite 108 . Building 2700 . Lalgadi Malakpet (V)
Genome Valley . Shameerpet
Hyderabad 500 078


Web Design: Firefly Communications